Pediatric & Hereditary Retinal Diseases: A Survey and Update

Wednesday, April 21, 2021 from 6:00 p.m. to 7:30 p.m.  Webinar - Remote Learning Event.

This event was originally scheduled for March 19, 2020 as an in-person seminar but was postponed due to Covid-19.


This live remote learning course is designed to provide clinicians with current information and strategies for the diagnosis and treatment of pediatric and hereditary retinal diseases. It focuses on the following topics: survey of pediatric retinal diseases and the use of gene therapy in hereditary retinal diseases.  The first half of the course uses case scenarios to provide in depth knowledge of pediatric retinal diseases.  It specifically addresses how to create a differential diagnosis for leukorcoria, the importance of ruling out retinoblastoma, a better understanding of retinovascular/exudative causes of pediatric retinal disease, a better understanding of hereditary vitreoretinal disorders in the pediatric population, how to differentiate congenital optic nerve head disorders and sequelae, and traumatic ocular injuries in pediatric patients.  The second half of the course provides updates on current gene therapies for the treatment of hereditary retinal diseases with the potential to restore vision or slow the progression of vision loss for these patients.


Dr. Joseph Boss and Dr. Liliya Sutherland.

Who Should Attend

Optometrists, ophthalmic specialists, general ophthalmologists, fellows and ophthalmology residents encompassing all levels of experience and knowledge.


  1. To better understand the presence and course of various conditions in the spectrum of pediatric retinal disease including disorder pathophysiology, clinical features, management options, and typical treatment course.
  2. To understand the mechanism of action and current status of gene and cell therapies for inherited retinal dystrophies and degenerations and how these therapies are altering the treatment of hereditary retinal diseases, potentially restoring vision or slowing the progression of vision loss.


This live activity is designated for a maximum of 1 CE Credit by COPE (Course Number 65900-PS, Activity ID Number 118664).

The Michigan State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Michigan State Medical Society and Foundation for Vision Research. The Michigan State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

Registration & Cancellation

Registration is accepted until 5:00 pm Monday, April 19, 2021.  You can register using the zoom link below or the Sign Up on our website.

Please email [email protected] if you need assistance.

Sign Up


Your support enables the Foundation for Vision Research to take part in research directly impacting the lives of patients in West Michigan and changing the landscape of treatment for retinal diseases for the entire population. A cure is in sight and you can help us reach it by making a tax-deductible donation to research today.  Tribute gifts can be made in honor or memory of a loved one.